Open tender · Germany · Contract notice
Open house Arzneimittelrabattverträge zum Wirkstoff Everolimus, ATC L04AH02
AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse
AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse in Germany is inviting bids for “Open house Arzneimittelrabattverträge zum Wirkstoff Everolimus, ATC L04AH02”. Bids close on 30 September 2027.
The work
Non-exclusive discount contracts for Everolimus-based medicinal products from 01.12.2025 to 30.11.2027 under an open-house model.
- Contracts are non-exclusive and open to all market participants
- Uniform conditions apply; no individual negotiations
- Contracts can be signed on the first of any month within the 24-month period
Key facts
- Contract period
- Maximum 24 months
- Submission
- Online, on the e-procurement portal
What it takes to qualify
Worth a closer look
- The tender is not a public contract under the EU procurement directive, but a publication for transparency purposes.
- The first award will be made at least 10 calendar days after publication in the Official Journal of the European Union.
Policy conditions
No reservation, preference or local-content restriction.
Documents to submit
- Signed contract documentsCan be submitted in 2-fold handwritten or electronically with qualified electronic signature
- Extract from AMIce databaseFor all medicinal products in distribution at contract conclusion